ATF4 knockdown in macrophage impairs glycolysis and mediates immune tolerance by targeting HK2 and HIF-1α ubiquitination in sepsis.

[1]  T. van der Poll,et al.  Glucose metabolism is upregulated in the mononuclear cell proteome during sepsis and supports endotoxin-tolerant cell function , 2022, Frontiers in Immunology.

[2]  Y. Qiu,et al.  NLRC3 expression in macrophage impairs glycolysis and host immune defense by modulating the NF-κB-NFAT5 complex during septic immunosuppression , 2022, Molecular therapy : the journal of the American Society of Gene Therapy.

[3]  Fengxue Zhang,et al.  Erythropoietin mediates re-programming of endotoxin-tolerant macrophages through PI3K/AKT signaling and protects mice against secondary infection , 2022, Frontiers in Immunology.

[4]  Xiaoting Wang,et al.  Metabolic reprogramming consequences of sepsis: adaptations and contradictions , 2022, Cellular and Molecular Life Sciences.

[5]  S. Hou,et al.  N6-methyladenosine demethylase FTO regulates inflammatory cytokine secretion and tight junctions in retinal pigment epithelium cells. , 2022, Clinical immunology.

[6]  S. C. Huang,et al.  PERK is a critical metabolic hub for immunosuppressive function in macrophages , 2022, Nature Immunology.

[7]  Peng Liu,et al.  Correction to: The transcription factor KLF14 regulates macrophage glycolysis and immune function by inhibiting HK2 in sepsis , 2022, Cellular & Molecular Immunology.

[8]  Q. Liao,et al.  TRPM7 silencing modulates glucose metabolic reprogramming to inhibit the growth of ovarian cancer by enhancing AMPK activation to promote HIF-1α degradation , 2022, Journal of Experimental & Clinical Cancer Research.

[9]  Xiaoli Wang,et al.  Immune effects of PI3K/Akt/HIF-1α-regulated glycolysis in polymorphonuclear neutrophils during sepsis , 2022, Critical Care.

[10]  Guangjian Fan,et al.  The transcription factor KLF14 regulates macrophage glycolysis and immune function by inhibiting HK2 in sepsis , 2022, Cellular & molecular immunology.

[11]  C. Zhan,et al.  LncRNA FAM83A-AS1 facilitates tumor proliferation and the migration via the HIF-1α/ glycolysis axis in lung adenocarcinoma , 2022, International Journal of Biological Sciences.

[12]  M. Arock,et al.  Monocyte distribution width (MDW) performance as an early sepsis indicator in the emergency department: comparison with CRP and procalcitonin in a multicenter international European prospective study , 2021, Critical Care.

[13]  Junnian Zheng,et al.  Trim21-mediated HIF-1α degradation attenuates aerobic glycolysis to inhibit renal cancer tumorigenesis and metastasis. , 2021, Cancer letters.

[14]  C. Goding,et al.  Acriflavine, a Potent Inhibitor of HIF-1α, Disturbs Glucose Metabolism and Suppresses ATF4-Protective Pathways in Melanoma under Non-hypoxic Conditions , 2020, Cancers.

[15]  Yucai Zhang,et al.  IL-22 ameliorates LPS-induced acute liver injury by autophagy activation through ATF4-ATG7 signaling , 2020, Cell Death & Disease.

[16]  J. Asara,et al.  The mTORC1-mediated activation of ATF4 promotes protein and glutathione synthesis downstream of growth signals , 2020, bioRxiv.

[17]  J. Auwerx,et al.  Inhibition of mitophagy drives macrophage activation and anti-bacterial defense during sepsis. , 2020, The Journal of clinical investigation.

[18]  J. Pépin,et al.  Cooperation Between Hypoxia-Inducible Factor 1α and Activating Transcription Factor 4 in Sleep Apnea-Mediated Myocardial Injury. , 2020, The Canadian journal of cardiology.

[19]  Zhuanchang Wu,et al.  Zhx2 Accelerates Sepsis by Promoting Macrophage Glycolysis via Pfkfb3 , 2020, The Journal of Immunology.

[20]  N. Hacohen,et al.  An immune-cell signature of bacterial sepsis , 2020, Nature Medicine.

[21]  Yan Zhang,et al.  Lidocaine attenuates lipopolysaccharide-induced inflammatory responses and protects against endotoxemia in mice by suppressing HIF1α-induced glycolysis. , 2020, International immunopharmacology.

[22]  R. Guedes,et al.  Unlocking the potential of HK2 in cancer metabolism and therapeutics. , 2020, Current medicinal chemistry.

[23]  Trevor J Pugh,et al.  GCN2 drives macrophage and MDSC function and immunosuppression in the tumor microenvironment , 2019, Science Immunology.

[24]  M. Netea,et al.  Current gaps in sepsis immunology: new opportunities for translational research. , 2019, The Lancet. Infectious diseases.

[25]  D. Foell,et al.  Synergistic Signaling of TLR and IFNα/β Facilitates Escape of IL-18 Expression from Endotoxin Tolerance , 2019, American journal of respiratory and critical care medicine.

[26]  I. Koutroulis,et al.  Sepsis Immunometabolism: From Defining Sepsis to Understanding How Energy Production Affects Immune Response , 2019, Critical care explorations.

[27]  Susan F. Fitzpatrick,et al.  Immunometabolism and Sepsis: A Role for HIF? , 2019, Front. Mol. Biosci..

[28]  C. Seymour,et al.  Monocyte Distribution Width: A Novel Indicator of Sepsis-2 and Sepsis-3 in High-Risk Emergency Department Patients* , 2019, Critical care medicine.

[29]  Ana S. H. Costa,et al.  Acute Iron Deprivation Reprograms Human Macrophage Metabolism and Reduces Inflammation In Vivo , 2019, Cell reports.

[30]  L. Virág,et al.  Programmed necrotic cell death of macrophages: Focus on pyroptosis, necroptosis, and parthanatos , 2019, Redox biology.

[31]  Christian M. Metallo,et al.  Increased Serine and One-Carbon Pathway Metabolism by PKCλ/ι Deficiency Promotes Neuroendocrine Prostate Cancer. , 2019, Cancer cell.

[32]  Eun-Kyoung Kim,et al.  TLR4 (toll-like receptor 4) activation suppresses autophagy through inhibition of FOXO3 and impairs phagocytic capacity of microglia , 2018, Autophagy.

[33]  Vijay Kumar.  Immunometabolism: Another Road to Sepsis and Its Therapeutic Targeting , 2018, Inflammation.

[34]  W. F. Abdo,et al.  Precision Immunotherapy for Sepsis , 2018, Front. Immunol..

[35]  Xinchun Chen,et al.  ATF4 Regulates CD4+ T Cell Immune Responses through Metabolic Reprogramming , 2018, Cell reports.

[36]  K. Rajapakshe,et al.  Metabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive breast cancer , 2018, Nature.

[37]  Yucai Zhang,et al.  Obeticholic acid protects mice against lipopolysaccharide-induced liver injury and inflammation. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[38]  Peter Nürnberg,et al.  Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study. , 2017, The Lancet. Respiratory medicine.

[39]  C. Seymour,et al.  Improved Early Detection of Sepsis in the ED With a Novel Monocyte Distribution Width Biomarker , 2017, Chest.

[40]  A. Engelbrecht,et al.  Hyperglycaemia in critically ill patients: the immune system’s sweet tooth , 2017, Critical Care.

[41]  H. Wong,et al.  SOCS1 is a negative regulator of metabolic reprogramming during sepsis. , 2017, JCI insight.

[42]  Amit A. Patel,et al.  The fate and lifespan of human monocyte subsets in steady state and systemic inflammation , 2017, The Journal of experimental medicine.

[43]  J. Kalbfleisch,et al.  Enhanced Glycolytic Metabolism Contributes to Cardiac Dysfunction in Polymicrobial Sepsis , 2017, The Journal of infectious diseases.

[44]  T. Rimmele,et al.  Modulation of LILRB2 protein and mRNA expressions in septic shock patients and after ex vivo lipopolysaccharide stimulation. , 2017, Human immunology.

[45]  T. Anthony,et al.  Role of activating transcription factor 4 in the hepatic response to amino acid depletion by asparaginase , 2017, Scientific Reports.

[46]  Alan E. Jones,et al.  Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 , 2017, Intensive Care Medicine.

[47]  M. Delano,et al.  The immune system's role in sepsis progression, resolution, and long‐term outcome , 2016, Immunological reviews.

[48]  R. Xavier,et al.  Succinate Dehydrogenase Supports Metabolic Repurposing of Mitochondria to Drive Inflammatory Macrophages , 2016, Cell.

[49]  Anna Rautanen,et al.  Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study , 2016, The Lancet. Respiratory medicine.

[50]  L. Joosten,et al.  Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis , 2016, Nature Immunology.

[51]  T. Rea,et al.  Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[52]  S. Miyamoto,et al.  HK2/hexokinase-II integrates glycolysis and autophagy to confer cellular protection , 2015, Autophagy.

[53]  R. Xavier,et al.  mTOR- and HIF-1α–mediated aerobic glycolysis as metabolic basis for trained immunity , 2014, Science.

[54]  M. Paye,et al.  Early and dynamic changes in gene expression in septic shock patients: a genome-wide approach , 2014, Intensive Care Medicine Experimental.

[55]  P. Enkhbaatar,et al.  The Immunobiology of Toll-Like Receptor 4 Agonists: From Endotoxin Tolerance to Immunoadjuvants , 2013, Shock.

[56]  B. Liu,et al.  ATF4 deficiency protects hepatocytes from oxidative stress via inhibiting CYP2E1 expression , 2013, Journal of cellular and molecular medicine.

[57]  Hongli Jiao,et al.  ATF4 promotes bone angiogenesis by increasing vegf expression and release in the bone environment , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[58]  Liang Zheng,et al.  Succinate is an inflammatory signal that induces IL-1β through HIF-1α , 2013, Nature.

[59]  B. Liu,et al.  Effects of ATF4 on PGC1α expression in brown adipose tissue and metabolic responses to cold stress. , 2013, Metabolism: clinical and experimental.

[60]  Yaping Tian,et al.  ATF4 is directly recruited by TLR4 signaling and positively regulates TLR4-trigged cytokine production in human monocytes , 2012, Cellular and Molecular Immunology.

[61]  Chunxia Wang,et al.  Effects of activating transcription factor 4 deficiency on carbohydrate and lipid metabolism in mammals , 2012, IUBMB life.

[62]  R. Hotchkiss,et al.  Immunosuppression in patients who die of sepsis and multiple organ failure. , 2011, JAMA.

[63]  N. Rosenthal,et al.  Calcineurin Splicing Variant Calcineurin A&bgr;1 Improves Cardiac Function After Myocardial Infarction Without Inducing Hypertrophy , 2011, Circulation.

[64]  Benjamin Tang,et al.  Development and validation of a novel molecular biomarker diagnostic test for the early detection of sepsis , 2011, Critical care.

[65]  Ying Du,et al.  ATF4 regulates lipid metabolism and thermogenesis , 2010, Cell Research.

[66]  J. Graff,et al.  Atf4 Regulates Obesity, Glucose Homeostasis, and Energy Expenditure , 2009, Diabetes.

[67]  A. Randolph,et al.  International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics* , 2005, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[68]  Xianzhong Xiao,et al.  Inhibition of Aerobic Glycolysis Promotes Neutrophil to Influx to The Infectious Site via CXCR2 In Sepsis. , 2019, Shock.

[69]  Adrian L Harris,et al.  Activating transcription factor 4. , 2008, The international journal of biochemistry & cell biology.